MAPT and Alzheimer disease: Studies have shown that olfactory impairment is a major part of cognitive impairment in AD, and olfactory impairment is highly correlated with Aβ deposition and tau hyperphosphorylation [7], especially OB [25], which occurs outside the cortex and hippocampus.